↓ Skip to main content

Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis

Overview of attention for article published in BMC Musculoskeletal Disorders, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
Published in
BMC Musculoskeletal Disorders, January 2013
DOI 10.1186/1471-2474-14-13
Pubmed ID
Authors

Sang-Cheol Bae, Suk Chyn Gun, Chi Chiu Mok, Rezaul Khandker, Henk W Nab, Andrew S Koenig, Bonnie Vlahos, Ron Pedersen, Amitabh Singh

Abstract

Patient reported outcomes (PROs) are especially useful in assessing treatments for rheumatoid arthritis (RA) since they measure dimensions of health-related quality of life that cannot be captured using strictly objective physiological measures. The aim of this study was to compare the effects of combination etanercept and methotrexate (ETN + MTX) versus combination synthetic disease modifying antirheumatic drugs (DMARDs) and methotrexate (DMARD + MTX) on PRO measures among RA patients from the Asia-Pacific region, a population not widely studied to date. Patients with established moderate to severe rheumatoid arthritis who had an inadequate response to methotrexate were studied.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Unknown 126 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 14%
Student > Bachelor 17 13%
Student > Ph. D. Student 16 13%
Other 13 10%
Researcher 13 10%
Other 23 18%
Unknown 28 22%
Readers by discipline Count As %
Medicine and Dentistry 49 38%
Pharmacology, Toxicology and Pharmaceutical Science 11 9%
Psychology 10 8%
Nursing and Health Professions 8 6%
Social Sciences 6 5%
Other 11 9%
Unknown 33 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2013.
All research outputs
#6,641,403
of 11,191,240 outputs
Outputs from BMC Musculoskeletal Disorders
#1,319
of 2,316 outputs
Outputs of similar age
#158,223
of 310,825 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#76
of 135 outputs
Altmetric has tracked 11,191,240 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,316 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,825 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.